WGSGeneDx Holdings Corp.
Services-Health Services
- Revenue
- $428M
- 40% YoY
- Operating margin
- -3.1%
- 60% YoY
- EBITDA
- −$3M
- 77% YoY
- Market cap
- —
- Employees
- —
- Net debt / EBITDA
- —
- $40M net debt
- AI in 10-K
- —
Red flags 0 of 9
- TSR below peersClear—3+ of last 5 years
- High CEO pay despite TSRClear—Median CEO pay ≥ $15M and TSR flag
- Active 13DClear0 filingsActive-intent 13D in 18 months
- Net insider sellingClear$0 netNet sales over $10M in 12 months
- Earnings not backed by cashClear—Cash flow under 80% of net income
- Dilutive SBCClear8% of revenueOver 10% of revenue
- Payouts exceed cash flowClear0% of cash flowBuybacks + dividends over cash flow
- Goodwill-heavyClear0% of assetsOver 40% of assets
- Shareholder dissentClear—Any vote under 80% support
Financials
| Metric | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | YoY |
|---|---|---|---|---|---|---|
| Revenue | $212M | $235M | $203M | $305M | $428M | 40% |
| Operating income | −$446M | −$668M | −$181M | −$23M | −$13M | 44% |
| Net income | −$245M | −$549M | −$176M | −$52M | −$21M | 60% |
| Operating cash flow | −$190M | −$319M | −$180M | −$28M | $33M | 217% |
| Capex | $9M | $7M | $5M | $5M | $19M | 246% |
| Stock-based comp | $219M | $42M | −$326K | $9M | $32M | 252% |
Deal filings
None.
13D filers
None on file.
Insider trading
- Open-market buys, 12 mo
- $0 · 0
- Open-market sells, 12 mo
- $2M · 12
- Net
- −$2M
Pay vs performance
| Year | CEO total comp | Comp actually paid | TSR (indexed) | Peer TSR |
|---|---|---|---|---|
| FY2025 | $14M | $43M | 1494 | 139 |
| FY2024 | $4M | $52M | 883 | 104 |
| FY2023 | $4M | $546K | 32 | 105 |